Barbara DeNearing
About
Barbara DeNearing is a scholar working on Infectious Diseases, Endocrinology and Molecular Biology.
According to data from OpenAlex, Barbara DeNearing has authored 21 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 20 papers in Endocrinology and 2 papers in Molecular Biology. Recurrent topics in Barbara DeNearing's work include Viral gastroenteritis research and epidemiology (20 papers), Escherichia coli research studies (20 papers) and Clostridium difficile and Clostridium perfringens research (9 papers). Barbara DeNearing is often cited by papers focused on Viral gastroenteritis research and epidemiology (20 papers), Escherichia coli research studies (20 papers) and Clostridium difficile and Clostridium perfringens research (9 papers). Barbara DeNearing collaborates with scholars based in United States, Switzerland and United Kingdom. Barbara DeNearing's co-authors include A. Louis Bourgeois, David A. Sack, Clayton Harro, Subhra Chakraborty, Richard I. Walker, Michael J. Darsley, Andrea Feller, Jessica Brubaker, Chad K. Porter and Mark S. Riddle and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Clinical Infectious Diseases.
In The Last Decade
Barbara DeNearing
20 papers receiving 708 citations
Peers
Barbara DeNearing
Felipe Del Canto Chile
Gudrun Wiklund Sweden
Carmen Contreras Peru
Jessica Brubaker United States
Mai Ngoc Lanh Vietnam
Khorshed Alam Bangladesh
Nadia Boisen United States
Ellen E. Higginson United States
Israel Nissan Israel
Kamrul Islam Bangladesh
Citations per year, relative to Barbara DeNearing Barbara DeNearing (= 1×)
peers
Felipe Del Canto
Countries citing papers authored by Barbara DeNearing
Since
Specialization
Citations
This map shows the geographic impact of Barbara DeNearing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara DeNearing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara DeNearing more than expected).
Fields of papers citing papers by Barbara DeNearing
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Barbara DeNearing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara DeNearing. The network helps show where Barbara DeNearing may publish in the future.
Co-authorship network of co-authors of Barbara DeNearing
This figure shows the co-authorship network connecting the top 25 collaborators of Barbara DeNearing. A scholar is included among the top collaborators of Barbara DeNearing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara DeNearing. Barbara DeNearing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Brubaker, Jessica, Kawsar R. Talaat, Chad K. Porter, et al.. (2025). Intestinal inflammation induced by heat-labile toxin-producing enterotoxigenic E: Coli infection and impact on immune responses in an experimental human challenge model. PLoS neglected tropical diseases. 19(10). e0013025–e0013025.
2.
Gutiérrez, Ramiro L., Chad K. Porter, Clayton Harro, et al.. (2024). Efficacy Evaluation of an Intradermally Delivered Enterotoxigenic Escherichia coli CF Antigen I Fimbrial Tip Adhesin Vaccine Coadministered with Heat-Labile Enterotoxin with LT(R192G) against Experimental Challenge with Enterotoxigenic E. coli H10407 in Healthy Adult Volunteers. Microorganisms. 12(2). 288–288.
3.
Talaat, Kawsar R., Chad K. Porter, Subhra Chakraborty, et al.. (2024). Validation of a Human Challenge Model Using an LT-Expressing Enterotoxigenic E. coli Strain (LSN03-016011) and Characterization of Potential Amelioration of Disease by an Investigational Oral Vaccine Candidate (VLA1701). Microorganisms. 12(4). 727–727.
4.
Clarkson, Kristen A., Kawsar R. Talaat, Cristina Alaimo, et al.. (2021). Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine. EBioMedicine. 66. 103308–103308.
5.
Talaat, Kawsar R., Cristina Alaimo, Patricia Martín, et al.. (2021). Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection. EBioMedicine. 66. 103310–103310.
6.
Chakraborty, Subhra, Arlo Randall, Tim J. Vickers, et al.. (2019). Interrogation of a live-attenuated enterotoxigenic Escherichia coli vaccine highlights features unique to wild-type infection. npj Vaccines. 4(1). 37–37.
7.
Harro, Clayton, A. Louis Bourgeois, David A. Sack, et al.. (2019). Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge. Vaccine. 37(14). 1978–1986.
8.
Savarino, Stephen J., Robin McKenzie, David R. Tribble, et al.. (2019). Hyperimmune Bovine Colostral Anti-CS17 Antibodies Protect Against Enterotoxigenic Escherichia coli Diarrhea in a Randomized, Doubled-Blind, Placebo-Controlled Human Infection Model. The Journal of Infectious Diseases. 220(3). 505–513.
9.
Chakraborty, Subhra, Clayton Harro, Barbara DeNearing, et al.. (2018). Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers. PLoS neglected tropical diseases. 12(4). e0006442–e0006442.
10.
Porter, Chad K., Mark S. Riddle, Kawsar R. Talaat, et al.. (2018). Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score. PLoS ONE. 13(3). e0194325–e0194325.
11.
Crofts, Alexander A., Simone M. Giovanetti, Frédéric Poly, et al.. (2018). Enterotoxigenic E. coli virulence gene regulation in human infections. Proceedings of the National Academy of Sciences. 115(38). E8968–E8976.
12.
Chakraborty, Subhra, Arlo Randall, Tim J. Vickers, et al.. (2018). Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine Development. The Journal of Infectious Diseases. 218(9). 1436–1446.
13.
Savarino, Stephen J., Robin McKenzie, David R. Tribble, et al.. (2017). Prophylactic Efficacy of Hyperimmune Bovine Colostral Antiadhesin Antibodies Against Enterotoxigenic Escherichia coli Diarrhea: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial. The Journal of Infectious Diseases. 216(1). 7–13.
14.
Harro, Clayton, David A. Sack, Kawsar R. Talaat, et al.. (2017). Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled Trial. Clinical Infectious Diseases. 66(9). 1435–1441.
15.
Porter, Chad K., Mark S. Riddle, David A. Sack, et al.. (2016). An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli. PLoS ONE. 11(3). e0149358–e0149358.
16.
Chakraborty, Subhra, Clayton Harro, Barbara DeNearing, et al.. (2016). Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects. Clinical and Vaccine Immunology. 23(4). 315–325.
17.
Chakraborty, Subhra, Clayton Harro, Barbara DeNearing, et al.. (2015). Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407. Clinical and Vaccine Immunology. 23(1). 55–64.
18.
Darsley, Michael J., Barbara DeNearing, David A. Sack, et al.. (2012). The Oral, Live Attenuated Enterotoxigenic Escherichia coli Vaccine ACE527 Reduces the Incidence and Severity of Diarrhea in a Human Challenge Model of Diarrheal Disease. Clinical and Vaccine Immunology. 19(12). 1921–1931.
19.
McKenzie, R., Chad K. Porter, Joyce A. Cantrell, et al.. (2011). Volunteer Challenge With Enterotoxigenic Escherichia coli That Express Intestinal Colonization Factor Fimbriae CS17 and CS19. The Journal of Infectious Diseases. 204(1). 60–64.
20.
Harro, Clayton, Subhra Chakraborty, Andrea Feller, et al.. (2011). Refinement of a Human Challenge Model for Evaluation of Enterotoxigenic Escherichia coli Vaccines. Clinical and Vaccine Immunology. 18(10). 1719–1727.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Felipe Del Canto Breakdown of academic impact, for papers by Gudrun Wiklund Breakdown of academic impact, for papers by Carmen Contreras Breakdown of academic impact, for papers by Jessica Brubaker Breakdown of academic impact, for papers by Mai Ngoc Lanh Breakdown of academic impact, for papers by Khorshed Alam Breakdown of academic impact, for papers by Nadia Boisen Breakdown of academic impact, for papers by Ellen E. Higginson Breakdown of academic impact, for papers by Israel Nissan Breakdown of academic impact, for papers by Kamrul Islam